The current study involved measuring the concentration of asprosin and adiponectin hormones, as well as cardiac troponin I and creatine kinase, in 100 samples of women divided as follows: 50 blood samples from obese women, 30 blood samples from thin women, and 20 blood samples from women of ideal weight. Their ages ranged between 25 and 45 years. This study was conducted from November 2021 to the end of April 2022. Blood samples were taken early in the morning after fasting for at least 6-8 hours, excluding pregnant and ill individuals.